How Akkermansia muciniphila Rewires Your Gut to Fight Disease and Aging
A comprehensive review reveals how one gut bacterium influences metabolism, immunity, cancer response, and longevity across multiple disease states.
20 articles
A comprehensive review reveals how one gut bacterium influences metabolism, immunity, cancer response, and longevity across multiple disease states.
A gut microbiome study links lactic acid and Akkermansia muciniphila to reduced anxiety by boosting serotonin production from tryptophan.
Researchers discover N-acetylmuramic acid from gut microbes inhibits colorectal cancer by blocking AKT1 signaling, offering new prevention insights.
New research reveals how Bilophila wadsworthia uses bacterial microcompartments to colonize the gut during high-fat diets.
Study reveals how specific gut microbes protect against cardiovascular inflammation, offering new therapeutic targets for vasculitis.
Review reveals how periodontal pathogens like P. gingivalis cross into the brain, triggering amyloid buildup and cognitive decline.
A 38-plex imaging study reveals how microglia shift along a continuous activation spectrum in Alzheimer's disease, with key protein changes in CA1.
A spatial multiomics atlas of human gum tissue reveals a preserved zonal immune architecture that guards the tooth-gum interface in health and disease.
Comprehensive review reveals how oral bacteria F. nucleatum drives colorectal cancer and other diseases through inflammation and immune evasion.
A gut-derived metabolite called phenylacetic acid rises with age and causes blood vessel cells to senesce, linking the microbiome to cardiovascular aging.
New cryo-EM structures reveal how AIFM1 recruits adenylate kinase AK2A to regulate mitochondrial energy balance and respiration.
Specific oral microbiome changes linked to aggressive Kaposi's sarcoma, offering new prognostic markers for this HIV-associated cancer.
Researchers discover that microbes from young mice can rejuvenate aged intestinal stem cells, opening new paths for longevity interventions.
Synthetic glycan microarrays reveal how human and mouse immune systems respond to Candida, pinpointing key oligosaccharide targets for diagnostics and vaccines.
New research reveals how oral microbiome imbalances trigger neuroinflammation and cognitive decline through systemic pathways.
Gut microbes convert ergothioneine into an electron acceptor that fuels anaerobic respiration, linking mushroom consumption to microbiome energy metabolism.
New research reveals how oral microbiome dysbiosis contributes to metabolic syndrome through inflammation and insulin resistance pathways.
New research reveals how a specific oral bacterium manipulates the immune system and microbiome to cause periodontal bone destruction.
Researchers discover how a bacterial enzyme helps H. pylori survive stomach acid and colonize the gut, opening new therapeutic avenues.
Meta-analysis reveals distinct oral bacteria patterns in autism, schizophrenia, depression and other mental disorders.